Experts explain challenges in studying CVD mortality in Hispanic subgroups
In response to a study published in JAMA Cardiology last week about a decrease in the number of Hispanics dying from cardiovascular disease, three physicians wrote a commentary explaining the challenges in concluding those findings.
Martha L. Daviglus, MD, PhD, and Amber Pirzada, MD, both from the University of Illinois at Chicago, and Jeremiah Stamler, MD, from Northwestern University, argued in the piece that it can be hard to draw concrete conclusions on the state of cardiovascular health for Hispanic groups because there is limited data on CVD outcomes for those with a Hispanic or Latino background.
Additionally, they argued that it is unclear whether characteristic associated with Hispanics as a whole can apply to all the sub-groups, like Mexicans, Cubans and Puerto Ricans.
To read more of their thoughts on the JAMA study, follow the link below:
Senior Writer
As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.